Shelter Pharma has secured an international purchase order worth USD12,285 from Genet International for the supply of veterinary feed supplements. Announced on July 27, 2026, the deal marks a step in the company's expansion into global markets, with management stating it will strengthen its export business and contribute to revenue growth. The order was disclosed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The transaction involves the supply of four specific veterinary products: Feedmin Bolus, Regulín Bolus, Lactocal Gel, and Buta-B Bolus. The order is classified as being in the normal course of business and does not involve any related party transactions. Management confirmed that neither the promoters nor group companies have any interest in Genet International.

Order Details

The breakdown of the purchase order by product is as follows:

The total consideration for the order stands at USD12,285. Execution timelines are to be mutually agreed upon as per the purchase order schedule. The company noted that this milestone reflects its growing presence in international markets.

What the Numbers Show

The order composition reveals a diversified product mix within the veterinary feed supplement segment. Lactocal Gel commands the highest unit price at USD2.80 per piece, contributing significantly to the total value despite a lower volume compared to the bolus products. The bolus products, priced at USD1.35 and USD1.90, rely on higher volumes (ranging from 1500 to 2500 units) to generate revenue. This mix suggests Shelter Pharma is leveraging both high-volume commodity items and higher-value specialized gels to penetrate the international market through Genet International.

Shelter Pharma has secured a purchase order from Verka Dairy Ludhiana for the supply of veterinary feed supplements, marking a new business acquisition in the domestic market. The order, valued at ₹50,347.50, was received in the normal course of business on July 24, 2026. This engagement with Verka Dairies, the flagship brand of MILKFED Punjab, underscores growing demand for specialized veterinary inputs among major dairy cooperatives in North India.

The transaction is classified as a domestic order and does not involve any related party transactions or interests from the promoter group. Shelter Pharma’s Board highlighted that the award reflects the client's confidence in the company's ability to deliver quality solutions efficiently. The order is expected to contribute positively to the company's future revenues and overall business growth.

Order Details

The purchase order covers two specific veterinary feed supplement products. The financial breakdown and product specifications are detailed below:

The company must execute the order within mutually agreed timelines as per the purchase order schedule. The products are intended for veterinary use within the dairy operations, specifically targeting animal health and productivity.

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was submitted to BSE Limited by Mustaqim Nisar Ahmed Sabugar, Managing Director of Shelter Pharma Limited. The filing confirms that the transaction is conducted at arm's length and falls outside the scope of related party transactions.

What the Numbers Show

While the absolute value of ₹50,347.50 is modest in the context of large-cap pharmaceutical contracts, the strategic significance lies in the client profile. Securing a contract with Verka Dairies, a major entity under MILKFED Punjab, validates Shelter Pharma’s product efficacy in a highly competitive regional market. For specialty chemical and veterinary input manufacturers, entry into the supply chain of large dairy cooperatives often serves as a gateway to recurring revenue streams, given the continuous need for animal health supplements. The absence of promoter interest ensures the transaction is purely commercial, reflecting organic demand rather than internal channeling.